Viewing Study NCT00915369


Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2026-03-04 @ 12:41 AM
Study NCT ID: NCT00915369
Status: UNKNOWN
Last Update Posted: 2010-02-08
First Post: 2009-06-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer
Sponsor: Fresenius Kabi Oncology Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: DO/NDR/02/2008/01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Dr. S. K. Mishra, Vice President - Clinical Research & Medical Services
Old Organization: Fresenius Kabi Oncology Ltd.

Collaborators